Genetic Signatures Ltd Cash Flow Reinvestment Rate

Latest as of June 2022: 1.32x

Genetic Signatures Ltd cash flow reinvestment rate. Genetic Signatures Ltd (GSS) has a Cash Flow Reinvestment Rate of 1.32x as of June 2022, reinvesting AU$2.55 Million (capex AU$2.55 Million ) from operating cash flow of AU$1.93 Million. See Genetic Signatures Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.32x

(Capex + Investments) / Operating CF

Total Reinvested

AU$2.55 Million

Capex + Investments

Operating Cash Flow

AU$1.93 Million

AUD

Capital Expenditures

AU$2.55 Million

AUD

Cash Flow Reinvestment Rate of Genetic Signatures Ltd (2021–2022)

Cash flow reinvestment rate of Genetic Signatures Ltd from 2021 to 2022. Historical reinvestment intensity for Genetic Signatures Ltd across 2 annual periods. Explore Genetic Signatures Ltd (GSS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Genetic Signatures Ltd Cash Flow Reinvestment Rate by Year (2021–2022)

Genetic Signatures Ltd cash flow reinvestment rate by year from 2021 to 2022. Year-by-year capital reinvestment analysis for Genetic Signatures Ltd. For the full cash flow conversion analysis, see Genetic Signatures Ltd cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2022	0.61x	AU$5.98 Million	AU$9.81 Million	AU$2.99 Million	▼ -74.3%
2021	2.37x	AU$9.96 Million	AU$4.20 Million	AU$4.98 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow